Cargando…
Long-term and age-dependent restoration of visual function in a mouse model of CNGB3-associated achromatopsia following gene therapy
Mutations in the CNGB3 gene account for >50% of all known cases of achromatopsia. Although of early onset, its stationary character and the potential for rapid assessment of restoration of retinal function following therapy renders achromatopsia a very attractive candidate for gene therapy. Here...
Autores principales: | Carvalho, Livia S., Xu, Jianhua, Pearson, Rachael A., Smith, Alexander J., Bainbridge, James W., Morris, Lynsie M., Fliesler, Steven J., Ding, Xi-Qin, Ali, Robin R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3140821/ https://www.ncbi.nlm.nih.gov/pubmed/21576125 http://dx.doi.org/10.1093/hmg/ddr218 |
Ejemplares similares
-
Ametropia and Emmetropization in CNGB3 Achromatopsia
por: Andersen, Mette Kjøbæk Gundestrup, et al.
Publicado: (2021) -
Residual Foveal Cone Structure in CNGB3-Associated Achromatopsia
por: Langlo, Christopher S., et al.
Publicado: (2016) -
Five novel CNGB3 gene mutations in Polish patients with achromatopsia
por: Wawrocka, Anna, et al.
Publicado: (2014) -
Novel CNGA3 and CNGB3 mutations in two Pakistani families with achromatopsia
por: Azam, Maleeha, et al.
Publicado: (2010) -
REPEATABILITY AND LONGITUDINAL ASSESSMENT OF FOVEAL CONE STRUCTURE IN CNGB3-ASSOCIATED ACHROMATOPSIA
por: Langlo, Christopher S., et al.
Publicado: (2017)